Cargando…
Real-world disparities and ethical considerations with access to CFTR modulator drugs: Mind the gap!
The third Sustainable Development Goal (SDG), to ensure healthy lives and promote well-being for all at all ages, has particular relevance and implementation challenges amongst people living with rare diseases such as cystic fibrosis (CF). Although the treatment and projected outcome of CF has signi...
Autores principales: | Zampoli, M., Morrow, B. M, Paul, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083423/ https://www.ncbi.nlm.nih.gov/pubmed/37050905 http://dx.doi.org/10.3389/fphar.2023.1163391 |
Ejemplares similares
-
Editorial: Real-world experience with CFTR modulator therapy
por: Tümmler, Burkhard, et al.
Publicado: (2023) -
Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis
por: Olivier, Margarete, et al.
Publicado: (2023) -
Airway Epithelial Inflammation In Vitro Augments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies
por: Gentzsch, Martina, et al.
Publicado: (2021) -
Gene Therapy: A Possible Alternative to CFTR Modulators?
por: Mercier, J., et al.
Publicado: (2021) -
Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators
por: Laselva, Onofrio, et al.
Publicado: (2018)